{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:33:57Z","timestamp":1791156837690,"version":"4.1.0"},"reference-count":362,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6,1]]},"DOI":"10.1210\/er.2008-0016","type":"journal-article","created":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T14:35:26Z","timestamp":1244212526000},"page":"343-375","source":"Crossref","is-referenced-by-count":378,"title":["History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target"],"prefix":"10.1210","volume":"30","author":[{"given":"R. J.","family":"Santen","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism (R.J.S.), University of Virginia, Charlottesville, Virginia 22908"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Brodie","sequence":"additional","affiliation":[{"name":"Emeritus Investigator (H.B.), Fulton, Maryland 20759"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. R.","family":"Simpson","sequence":"additional","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research (E.R.S.), Melbourne 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. K.","family":"Siiteri","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology (P.K.S.), University of California at San Francisco, San Francisco, California 94143"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brodie","sequence":"additional","affiliation":[{"name":"Department of Pharmacology (A.B.), School of Medicine, University of Maryland, Baltimore, Maryland 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041122241475200_R1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0021-9258(18)76577-0","article-title":"Characterization of theelol.","volume":"91","author":"Thayer","year":"1931","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0021-9258(18)76871-3","article-title":"The preparation of the crystalline follicular ovarian hormone: theelin.","volume":"87","author":"Veler","year":"1930","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/BF01506919","article-title":"Uber \u201cProgynon\u201d ein krystallisiertes weibliches sexualhormon.","volume":"17","author":"Butenandt","year":"1929","journal-title":"Die Naturwissenschaften"},{"key":"2019041122241475200_R4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ange.19310444602","article-title":"Uber die chemische untersuchung der sexualhormone.","volume":"44","author":"Butenandt","year":"1931","journal-title":"Zeitschrift fur Angewandte Chemie"},{"key":"2019041122241475200_R5","author":"Fieser","year":"1959"},{"key":"2019041122241475200_R6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.2004-0020","article-title":"Estrogen\u2013the good, the bad, and the unexpected.","volume":"26","author":"Simpson","year":"2005","journal-title":"Endocr Rev"},{"key":"2019041122241475200_R7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jcem.87.4.8417","article-title":"Clinical review 144: estrogen and the male skeleton.","volume":"87","author":"Khosla","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0009-9120(81)90964-4","article-title":"Feedback control of luteinizing hormone and follicle-stimulating hormone secretion by testosterone and estradiol in men: physiological and clinical implications.","volume":"14","author":"Santen","year":"1981","journal-title":"Clin Biochem"},{"key":"2019041122241475200_R9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsbmb.2005.04.020","article-title":"Aromatase in testis: expression and role in male reproduction.","volume":"95","author":"Lambard","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1172\/JCI108796","article-title":"Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy.","volume":"60","author":"Hemsell","year":"1977","journal-title":"J Clin Invest"},{"key":"2019041122241475200_R11","author":"Bernard","year":"1865"},{"key":"2019041122241475200_R12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/133494a0","article-title":"Oestrogenic hormone in the urine of the stallion.","volume":"133","author":"Zondek","year":"1934","journal-title":"Nature"},{"key":"2019041122241475200_R13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(00)88745-0","article-title":"Transformation of male sex hormones into a substance with the action of a female hormone.","volume":"133","author":"Steinach","year":"1937","journal-title":"Lancet"},{"key":"2019041122241475200_R14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0006-3002(55)90395-4","article-title":"Conversion of 19-hydroxy-\u03b44-androstene-3,17-dione to estrone by endocrine tissue.","volume":"17","author":"Meyer","year":"1955","journal-title":"Biochim Biophys Acta"},{"key":"2019041122241475200_R15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1530\/acta.0.0180148","article-title":"The conversion of \u03b4 4-androstene-3,17-dione-4-C14 and dehydroepiandrosterone by bovine adrenal homogenate preparations.","volume":"18","author":"Meyer","year":"1955","journal-title":"Acta Endocrinol"},{"key":"2019041122241475200_R16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0021-9258(18)70286-X","article-title":"Biological aromatization of steroids.","volume":"234","author":"Ryan","year":"1959","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0021-9258(18)65207-X","article-title":"The conversion of testosterone-3-C14 to C14-estradiol-17\u03b2 by human ovarian tissue.","volume":"221","author":"Baggett","year":"1956","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R18","author":"Gut","year":"1962"},{"key":"2019041122241475200_R19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1210\/endo-92-3-866","article-title":"Studies on the mechanism of estrogen biosynthesis. 8. The development of inhibitors of the enzyme system in human placenta.","volume":"92","author":"Schwarzel","year":"1973","journal-title":"Endocrinology"},{"key":"2019041122241475200_R20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/endo-71-6-920","article-title":"Biosynthesis of estrogens.","volume":"71","author":"Gual","year":"1962","journal-title":"Endocrinology"},{"key":"2019041122241475200_R21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-291X(61)90140-1","article-title":"The intermediate steps in the biosynthesis of estrogens from androgens.","volume":"6","author":"Morato","year":"1961","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122241475200_R22","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1016\/S0021-9258(20)79735-8","article-title":"Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione.","volume":"249","author":"Thompson Jr","year":"1974","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R23","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/S0021-9258(20)79736-X","article-title":"The involvement of human placental microsomal cytochrome P-450 in aromatization.","volume":"249","author":"Thompson Jr","year":"1974","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R24","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0021-9258(17)43462-4","article-title":"Immunological probe of estrogen biosynthesis. Evidence for the 2 \u03b2-hydroxylative pathway in aromatization of androgens.","volume":"259","author":"Hahn","year":"1984","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R25","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1021\/bi00839a013","article-title":"Stereochemistry of estrogen biosynthesis.","volume":"8","author":"Fishman","year":"1969","journal-title":"Biochemistry"},{"key":"2019041122241475200_R26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0039-128X(87)90024-9","article-title":"Concerning the pathway from 19-oxoandrost-4-ene-3,17-dione to estrone.","volume":"50","author":"Caspi","year":"1987","journal-title":"Steroids"},{"key":"2019041122241475200_R27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/pro.5560040605","article-title":"A three-dimensional model of aromatase cytochrome P450.","volume":"4","author":"Graham-Lorence","year":"1995","journal-title":"Protein Science"},{"key":"2019041122241475200_R28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/me.2006-0281","article-title":"Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase.","volume":"21","author":"Hong","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2019041122241475200_R29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jsbmb.2004.12.040","article-title":"New assumptions about oxidative processes involved in steroid hormone biosynthesis: is the role of cytochrome P-450-activated dioxygen limited to hydroxylation reactions or are dioxygen insertion reactions also possible?","volume":"94","author":"Lieberman","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature07614","article-title":"Structural basis for androgen specificity and oestrogen synthesis in human aromatase.","volume":"457","author":"Ghosh","year":"2009","journal-title":"Nature"},{"key":"2019041122241475200_R31","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1021\/ja00878a033","article-title":"The stereochemical course of catalytic hydrogenation of ring A unsaturated steroids.","volume":"84","author":"Brodie","year":"1962","journal-title":"J Am Chem Soc"},{"key":"2019041122241475200_R32","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1021\/ja00878a032","article-title":"The mechanism of estrogen biosynthesis.","volume":"84","author":"Morato","year":"1962","journal-title":"J Am Chem Soc"},{"key":"2019041122241475200_R33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/bi00841a005","article-title":"Studies on the mechanism of estrogen biosynthesis. 3. The stereochemistry of aromatization of C19 and C18 steroids.","volume":"7","author":"Townsley","year":"1968","journal-title":"Biochemistry"},{"key":"2019041122241475200_R34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000179053","article-title":"Subcellular distribution of aromatase in human placenta and ovary.","volume":"11","author":"Thompson Jr","year":"1979","journal-title":"Horm Res"},{"key":"2019041122241475200_R35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/jm00383a017","article-title":"Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives.","volume":"28","author":"Marsh","year":"1985","journal-title":"J Med Chem"},{"key":"2019041122241475200_R36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0039-128X(83)90069-7","article-title":"7 \u03b1-Substituted androstenediones as effective in vitro and in vivo inhibitors of aromatase.","volume":"50","author":"Brueggemeier","year":"1987","journal-title":"Steroids"},{"key":"2019041122241475200_R37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0960-0760(90)90488-7","article-title":"Biochemical and pharmacological development of steroidal inhibitors of aromatase.","volume":"37","author":"Brueggemeier","year":"1990","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0039-128X(82)90151-9","article-title":"Synthesis and evaluation of 10 \u03b2-substituted 4-estrene-3, 17-diones as inhibitors of human placental microsomal aromatase.","volume":"39","author":"Marcotte","year":"1982","journal-title":"Steroids"},{"key":"2019041122241475200_R39","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/ja01033a050","article-title":"Studies on the mechanism of estrogen biosynthesis. VI. The stereochemistry of hydrogen elimination at C-2 during aromatization.","volume":"91","author":"Brodie","year":"1969","journal-title":"J Am Chem Soc"},{"key":"2019041122241475200_R40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/ja01033a050","article-title":"Studies on the mechanism of estrogen biosynthesis VI. The stereochemistry of hydrogen elimination of C-2 during aromatization.","volume":"91","author":"Brodie","year":"1969","journal-title":"J Am Chem Soc"},{"key":"2019041122241475200_R41","author":"Bolton"},{"key":"2019041122241475200_R42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/bj1300019Pb","article-title":"Inhibition studies on the aromatization of androst-4-ene-3,17-dione by human placental microsomal preparations.","volume":"130","author":"Chakraborty","year":"1972","journal-title":"Biochem J"},{"key":"2019041122241475200_R43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.steroids.2006.10.009","article-title":"Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.","volume":"72","author":"Jordan","year":"2007","journal-title":"Steroids"},{"key":"2019041122241475200_R44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/jrf.0.0130101","article-title":"A new derivative of triphenylethylene: effect on implantation and mode of action in rats.","volume":"13","author":"Harper","year":"1967","journal-title":"J Reprod Fertil"},{"key":"2019041122241475200_R45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/212087a0","article-title":"Contrasting endocrine activities of cis and trans isomers in a series of substituted triphenylethylenes.","volume":"212","author":"Harper","year":"1966","journal-title":"Nature"},{"key":"2019041122241475200_R46","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1210\/jcem-49-5-672","article-title":"Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using \u03b4 1-testololactone.","volume":"49","author":"Barone","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/jcem-36-2-207","article-title":"Source of estrogen production in postmenopausal women.","volume":"36","author":"Grodin","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R48","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1210\/jcem-27-8-1103","article-title":"Plasma precursors of estrogen. I. Extent of conversion of plasma \u03b4-4-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females.","volume":"27","author":"MacDonald","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0039-128X(66)90001-8","article-title":"The in vivo mechanisms of origin of estrogen in subjects with trophoblastic tumors.","volume":"8","author":"MacDonald","year":"1966","journal-title":"Steroids"},{"key":"2019041122241475200_R50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0022-4731(75)90149-1","article-title":"Studies of human placental aromatase.","volume":"6","author":"Siiteri","year":"1975","journal-title":"J Steroid Biochem"},{"key":"2019041122241475200_R51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1210\/jcem-26-7-751","article-title":"Placental estrogen biosynthesis during human pregnancy.","volume":"26","author":"Siiteri","year":"1966","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R52","first-page":"726","volume":"132","author":"Siiteri","journal-title":"Excerpta Medica Foundation, International Congress Series"},{"key":"2019041122241475200_R53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1749-6632.1973.tb47608.x","article-title":"Studies on the aromatization of C-19 androgens.","volume":"212","author":"Thompson","year":"1973","journal-title":"Ann NY Acad Sci"},{"key":"2019041122241475200_R54","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jcem-35-4-627","article-title":"Conversion of androstenedione to estrone by human tissue.","volume":"35","author":"Schindler","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/bjc.1975.82","article-title":"Biosynthesis of 17\u03b2-oestradiol in human breast carcinoma tissue and a novel method for its characterization.","volume":"31","author":"Adams","year":"1975","journal-title":"Br J Cancer"},{"key":"2019041122241475200_R56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0039-128X(79)90027-8","article-title":"Aromatization of androgens by human breast cancer.","volume":"33","author":"Abul-Hajj","year":"1979","journal-title":"Steroids"},{"issue":"8 Suppl","key":"2019041122241475200_R57","first-page":"3369s","article-title":"Aromatase in human breast carcinoma","volume":"42","author":"Perel","year":"1982","journal-title":"Cancer Res"},{"key":"2019041122241475200_R58","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jcem-57-6-1125","article-title":"Biological significance of aromatase activity in human breast tumors.","volume":"57","author":"Tilson-Mallett","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R59","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-#","article-title":"Prognostic value of breast cancer aromatase.","volume":"70","author":"Lipton","year":"1992","journal-title":"Cancer"},{"key":"2019041122241475200_R60","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1210\/endo.137.7.8770932","article-title":"Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers.","volume":"137","author":"Lu","year":"1996","journal-title":"Endocrinology"},{"key":"2019041122241475200_R61","first-page":"627","article-title":"Stromal spindle cells contain aromatase in human breast tumors.","volume":"79","author":"Santen","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R62","first-page":"927","article-title":"In situ aromatization enhances breast tumor estradiol levels and cellular proliferation.","volume":"58","author":"Yue","year":"1998","journal-title":"Cancer Res"},{"key":"2019041122241475200_R63","first-page":"3843","article-title":"Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.","volume":"81","author":"Agarwal","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R64","first-page":"4042","article-title":"Aromatase and 17 \u03b2-hydroxysteroid dehydrogenase type 1 in human breast carcinoma.","volume":"81","author":"Sasano","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R65","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.biopha.2003.09.007","article-title":"Intracrine mechanism of estrogen synthesis in breast cancer.","volume":"57","author":"Suzuki","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"2019041122241475200_R66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0960-0760(01)00148-0","article-title":"Local endocrine effects of aromatase inhibitors within the breast.","volume":"79","author":"Miller","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsbmb.2005.04.027","article-title":"The validation of new aromatase monoclonal antibodies for immunohistochemistry\u2013a correlation with biochemical activities in 46 cases of breast cancer.","volume":"95","author":"Sasano","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 9","key":"2019041122241475200_R68","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1023\/A:1006081729828","article-title":"Demonstration of aromatase activity and its regulation in breast tumor and benign breast fibroblasts","volume":"49","author":"Santen","year":"1998","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl 1","key":"2019041122241475200_R69","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1023\/A:1006033813899","article-title":"Comparison of biochemical aromatase activity with aromatase immunohistochemistry in human breast carcinomas","volume":"49","author":"Shenton","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R70","first-page":"837","article-title":"Regulated CYP19 aromatase transcription in breast stromal fibroblasts.","volume":"85","author":"Pauley","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R71","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-06-3105","article-title":"Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.","volume":"67","author":"Miki","year":"2007","journal-title":"Cancer Res"},{"key":"2019041122241475200_R72","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0960-0760(98)00143-5","article-title":"Macrophages, estrogen and the microenvironment of breast cancer.","volume":"67","author":"Mor","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R73","first-page":"4625","article-title":"Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.","volume":"56","author":"Leek","year":"1996","journal-title":"Cancer Res"},{"key":"2019041122241475200_R74","first-page":"1460","article-title":"Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.","volume":"81","author":"Pasqualini","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0960-0760(03)00364-9","article-title":"Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.","volume":"86","author":"Geisler","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R76","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1210\/jc.2004-0766","article-title":"Recombinant cell ultrasensitive bioassay for measurement of estrogens in postmenopausal women.","volume":"90","author":"Wang","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0960-0760(02)00047-X","article-title":"Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues.","volume":"81","author":"Larionov","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R78","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0277-5379(86)90151-3","article-title":"Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer.","volume":"22","author":"Reed","year":"1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2019041122241475200_R79","author":"Dunbier"},{"key":"2019041122241475200_R80","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.296.6624.741","article-title":"Aromatase activity in adipose tissue from breast quadrants: a link with tumour site.","volume":"296","author":"O'Neill","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2019041122241475200_R81","first-page":"1273","article-title":"Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast.","volume":"81","author":"Bulun","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R82","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1210\/endo.137.12.8940410","article-title":"Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.","volume":"137","author":"Zhao","year":"1996","journal-title":"Endocrinology"},{"key":"2019041122241475200_R83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1016121822916","article-title":"Overview of the pharmacology of the aromatase inactivator exemestane.","volume":"74","author":"Brueggemeier","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R84","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","article-title":"Nonsteroidal antiinflammatory drugs and breast cancer.","volume":"7","author":"Harris","year":"1996","journal-title":"Epidemiology"},{"key":"2019041122241475200_R85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0960-0760(00)00040-6","article-title":"Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues.","volume":"72","author":"Chetrite","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/jcem-59-1-29","article-title":"In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.","volume":"59","author":"Santner","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R87","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2004-0003","article-title":"Steroid sulfatase: molecular biology, regulation, and inhibition.","volume":"26","author":"Reed","year":"2005","journal-title":"Endocr Rev"},{"key":"2019041122241475200_R88","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0960-0760(96)00065-9","article-title":"Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase.","volume":"58","author":"Masamura","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R89","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/endo-100-6-1684","article-title":"The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer.","volume":"100","author":"Brodie","year":"1977","journal-title":"Endocrinology"},{"key":"2019041122241475200_R90","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1021\/bi00666a030","article-title":"Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.","volume":"15","author":"Bellino","year":"1976","journal-title":"Biochemistry"},{"key":"2019041122241475200_R91","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm00208a002","article-title":"Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.","volume":"21","author":"Brueggemeier","year":"1978","journal-title":"J Med Chem"},{"key":"2019041122241475200_R92","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0022-4731(86)90069-5","article-title":"1-Methyl-1,4-androstadiene-3,17-dione (SH 489): characterization of an irreversible inhibitor of estrogen biosynthesis.","volume":"24","author":"Henderson","year":"1986","journal-title":"J Steroid Biochem"},{"key":"2019041122241475200_R93","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1016\/S0021-9258(18)61365-1","article-title":"Inhibition of aromatase cytochrome P-450 by 10-oxirane and 10-thiirane substituted androgens. Implications for the structure of the active site.","volume":"262","author":"Kellis Jr","year":"1987","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0039-128X(83)90066-1","article-title":"Stereoselective inhibition of human placental aromatase.","volume":"50","author":"Childers","year":"1987","journal-title":"Steroids"},{"key":"2019041122241475200_R95","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/jm00383a014","article-title":"Thiol-containing androgens as suicide substrates of aromatase.","volume":"28","author":"Bednarski","year":"1985","journal-title":"J Med Chem"},{"key":"2019041122241475200_R96","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0039-128X(85)90084-4","article-title":"Novel silylated steroids as aromatase inhibitors.","volume":"45","author":"Burkhart","year":"1985","journal-title":"Steroids"},{"key":"2019041122241475200_R97","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1021\/jm00095a030","article-title":"Time-dependent inhibition of human placental aromatase with a 2,19-methyleneoxy-bridged androstenedione.","volume":"35","author":"Peet","year":"1992","journal-title":"J Med Chem"},{"key":"2019041122241475200_R98","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0960-0760(93)90269-3","article-title":"Biological characterization of A-ring steroids.","volume":"44","author":"Johnston","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00682739","article-title":"Aromatase inhibitors\u2014mechanisms of steroidal inhibitors.","volume":"30","author":"Brueggemeier","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0039-128X(81)90087-8","article-title":"Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.","volume":"38","author":"Brodie","year":"1981","journal-title":"Steroids"},{"key":"2019041122241475200_R101","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0006-291X(81)90897-4","article-title":"The time-dependent inactivation of aromatase by 17\u03b2-hydroxy-10-methylthioestra-1,4-dien-3-one.","volume":"103","author":"Flynn","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122241475200_R102","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0021-9258(19)69924-2","article-title":"10 \u03b2-Propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis.","volume":"256","author":"Covey","year":"1981","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R103","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/prot.20829","article-title":"Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes.","volume":"62","author":"Favia","year":"2006","journal-title":"Proteins"},{"key":"2019041122241475200_R104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/endo-106-1-19","article-title":"Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione.","volume":"106","author":"Brodie","year":"1980","journal-title":"Endocrinology"},{"key":"2019041122241475200_R105","first-page":"104","article-title":"On the treatment of inoperable cases of carcinoma of the mamma","volume":"II","author":"Beatson","year":"1896","journal-title":"Suggestions for a new method of treatment with illustrative cases. Lancet"},{"key":"2019041122241475200_R106","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/edrv-11-2-221","article-title":"Endocrine treatment of breast cancer in women.","volume":"11","author":"Santen","year":"1990","journal-title":"Endocr Rev"},{"key":"2019041122241475200_R107","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/00325481.1957.11691813","article-title":"Endocrine therapy of metastatic breast cancer.","volume":"21","author":"Lipsett","year":"1957","journal-title":"Postgrad Med"},{"key":"2019041122241475200_R108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/1097-0142(195701\/02)10:1<111::AID-CNCR2820100115>3.0.CO;2-L","article-title":"Bilateral adrenalectomy in the palliation of metastatic breast cancer.","volume":"10","author":"Lipsett","year":"1957","journal-title":"Cancer"},{"key":"2019041122241475200_R109","first-page":"342","article-title":"Treatment of breast cancer with antiestrogen: approach to medical hypophysectomy?","volume":"90","author":"Manni","year":"1977","journal-title":"Trans Assoc Am Physicians"},{"key":"2019041122241475200_R110","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/1097-0142(196309)16:9<1113::AID-CNCR2820160905>3.0.CO;2-N","article-title":"Hormonal therapy in cancer of the breast. XXII. Effect of 17\u03b1-methyl-5\u03b2-dihydrotestosterone on clinical course and hormonal excretion.","volume":"16","author":"Segaloff","year":"1963","journal-title":"Cancer"},{"key":"2019041122241475200_R111","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1001\/jama.1977.03270460065023","article-title":"Diethylstilbestrol: recommended dosages for different categories of breast cancer patients. Report of the Cooperative Breast Cancer Group.","volume":"237","author":"Carter","year":"1977","journal-title":"JAMA"},{"key":"2019041122241475200_R112","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jcem-27-9-1239","article-title":"Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.","volume":"27","author":"Cash","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1097-0142(197307)32:1<31::AID-CNCR2820320104>3.0.CO;2-5","article-title":"Preliminary trial of aminoglutethimide in breast cancer.","volume":"32","author":"Griffiths","year":"1973","journal-title":"Cancer"},{"key":"2019041122241475200_R114","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/1097-0142(197702)39:2<542::AID-CNCR2820390224>3.0.CO;2-R","article-title":"Medical and surgical adrenalectomy in patients with advanced breast carcinoma.","volume":"39","author":"Newsome","year":"1977","journal-title":"Cancer"},{"key":"2019041122241475200_R115","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.1974.03240120029015","article-title":"Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism.","volume":"230","author":"Santen","year":"1974","journal-title":"JAMA"},{"key":"2019041122241475200_R116","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01806259","article-title":"Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.","volume":"1","author":"Santen","year":"1981","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R117","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1210\/jcem-47-6-1257","article-title":"Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.","volume":"47","author":"Santen","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R118","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2001.19.3.881","article-title":"Aromatase inhibitors in the treatment and prevention of breast cancer.","volume":"19","author":"Goss","year":"2001","journal-title":"J Clin Oncol"},{"key":"2019041122241475200_R119","first-page":"CD003370","article-title":"Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women","volume":"Reviews","author":"Gibson","year":"2007","journal-title":"Cochrane Database of Systematic"},{"key":"2019041122241475200_R120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1521-690X(03)00051-4","article-title":"Oestrogen suppression\u2014lessons from clinical studies.","volume":"18","author":"Lonning","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2019041122241475200_R121","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00000421-200308001-00003","article-title":"A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer","volume":"26","author":"Rose","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"2019041122241475200_R122","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s101470200040","article-title":"The evolving role of aromatase inhibitors in breast cancer.","volume":"7","author":"Mokbel","year":"2002","journal-title":"Int J Clin Oncol"},{"key":"2019041122241475200_R123"},{"key":"2019041122241475200_R124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2710.1998.00145.x","article-title":"A review of the newer aromatase inhibitors in the management of metastatic breast cancer.","volume":"23","author":"Reddy","year":"1998","journal-title":"J Clin Pharm Ther"},{"key":"2019041122241475200_R125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00682741","article-title":"First generation aromatase inhibitors\u2014aminoglutethimide and testololactone.","volume":"30","author":"Cocconi","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00682742","article-title":"Second generation aromatase inhibitor\u20144-hydroxyandrostenedione.","volume":"30","author":"Dowsett","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R127","first-page":"7","article-title":"Obituary regarding William McGuire.","volume":"23","author":"Santen","year":"1992","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0039-128X(82)90050-2","article-title":"Plasma estrone-sulfate: assessment of reduced estrogen production during treatment of metastatic breast carcinoma.","volume":"39","author":"Samojlik","year":"1982","journal-title":"Steroids"},{"issue":"8 Suppl","key":"2019041122241475200_R129","first-page":"3349s","article-title":"Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast","volume":"42","author":"Samojlik","year":"1982","journal-title":"Cancer Res"},{"issue":"8 Suppl","key":"2019041122241475200_R130","first-page":"3397s","article-title":"Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses","volume":"42","author":"Santen","year":"1982","journal-title":"Cancer Res"},{"key":"2019041122241475200_R131","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/1097-0142(197906)43:6<2207::AID-CNCR2820430608>3.0.CO;2-1","article-title":"A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer.","volume":"43","author":"Harvey","year":"1979","journal-title":"Cancer"},{"key":"2019041122241475200_R132","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198109033051003","article-title":"A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.","volume":"305","author":"Santen","year":"1981","journal-title":"N Engl J Med"},{"key":"2019041122241475200_R133","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jcem-51-3-473","article-title":"Resistance of the ovary to blockade of aromatization with aminoglutethimide.","volume":"51","author":"Santen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"8 Suppl","key":"2019041122241475200_R134","first-page":"3430s","article-title":"Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma","volume":"42","author":"Smith","year":"1982","journal-title":"Cancer Res"},{"key":"2019041122241475200_R135","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/1097-0142(19940115)73:2<354::AID-CNCR2820730220>3.0.CO;2-J","article-title":"Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen.","volume":"73","author":"Gale","year":"1994","journal-title":"Cancer"},{"issue":"8 Suppl","key":"2019041122241475200_R136","first-page":"3451s","article-title":"Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer","volume":"42","author":"Harvey","year":"1982","journal-title":"Cancer Res"},{"issue":"8 Suppl","key":"2019041122241475200_R137","first-page":"3468s","article-title":"Closing remarks to the conference, Aromatase: New Perspectives for Breast Cancer","volume":"42","author":"Lipton","year":"1982","journal-title":"Cancer Res"},{"issue":"8 Suppl","key":"2019041122241475200_R138","first-page":"3268s","article-title":"Introduction to the conference, Aromatase: New Perspectives for Breast Cancer","volume":"42","author":"Santen","year":"1982","journal-title":"Cancer Res"},{"key":"2019041122241475200_R139","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(85)91955-5","article-title":"Low-dose aminoglutethimide and aromatase inhibition.","volume":"1","author":"Dowsett","year":"1985","journal-title":"Lancet"},{"key":"2019041122241475200_R140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/bjc.1983.100","article-title":"Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.","volume":"47","author":"Harris","year":"1983","journal-title":"Br J Cancer"},{"key":"2019041122241475200_R141","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0277-5379(84)90230-X","article-title":"Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer.","volume":"20","author":"Harris","year":"1984","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2019041122241475200_R142","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2265.1985.tb01083.x","article-title":"Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer.","volume":"22","author":"Stuart-Harris","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122241475200_R143","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/jcem-51-3-462","article-title":"Potency of the effect of D-stereoisomer of aminoglutethimide on adrenal and extraadrenal steroidogenesis.","volume":"51","author":"Samojlik","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R144","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0140-6736(84)92795-8","article-title":"4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer.","volume":"2","author":"Coombes","year":"1984","journal-title":"Lancet"},{"key":"2019041122241475200_R145","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/sj.onc.1205420","article-title":"Phosphorylation of human estrogen receptor \u03b1 at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.","volume":"21","author":"Chen","year":"2002","journal-title":"Oncogene"},{"key":"2019041122241475200_R146","first-page":"1957","article-title":"Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.","volume":"47","author":"Dowsett","year":"1987","journal-title":"Cancer Res"},{"key":"2019041122241475200_R147","first-page":"1306","article-title":"Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.","volume":"49","author":"Dowsett","year":"1989","journal-title":"Cancer Res"},{"key":"2019041122241475200_R148","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0022-4731(86)90128-7","article-title":"Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat.","volume":"24","author":"Goss","year":"1986","journal-title":"J Steroid Biochem"},{"issue":"Suppl 7","key":"2019041122241475200_R149","first-page":"S19","article-title":"Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer","volume":"5","author":"Pe\u0301rez Carrio\u0301n","year":"1994","journal-title":"Ann Oncol"},{"key":"2019041122241475200_R150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsbmb.2005.04.015","article-title":"Endocrine effects of aromatase inhibitors and inactivators in vivo: review of data and method limitations.","volume":"95","author":"Geisler","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R151","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0039-128X(83)90068-5","article-title":"In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A.","volume":"50","author":"Steele","year":"1987","journal-title":"Steroids"},{"key":"2019041122241475200_R152","first-page":"1162","article-title":"The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.","volume":"70","author":"Demers","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R153","first-page":"571","article-title":"The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects.","volume":"74","author":"Trunet","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R154","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00682744","article-title":"Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients.","volume":"30","author":"Demers","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/annonc\/mdg014","article-title":"Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer.","volume":"14","author":"Tominaga","year":"2003","journal-title":"Ann Oncol"},{"key":"2019041122241475200_R156","first-page":"267","article-title":"Laboratory models of breast cancer to aid the elucidation of antiestrogen action.","volume":"109","author":"Jordan","year":"1987","journal-title":"J Lab Clin Med"},{"key":"2019041122241475200_R157","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00047755","article-title":"Human tumor xenografts as model for drug testing.","volume":"7","author":"Mattern","year":"1988","journal-title":"Cancer Metastasis Rev"},{"key":"2019041122241475200_R158","first-page":"4893","article-title":"Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.","volume":"6","author":"Lee","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"2019041122241475200_R159","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/jnci\/87.10.746","article-title":"Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.","volume":"87","author":"Osborne","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"2019041122241475200_R160","first-page":"5092","article-title":"A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene.","volume":"54","author":"Yue","year":"1994","journal-title":"Cancer Res"},{"key":"2019041122241475200_R161","first-page":"6949","article-title":"Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening.","volume":"50","author":"Zhou","year":"1990","journal-title":"Cancer Res"},{"key":"2019041122241475200_R162","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0960-0760(93)90267-Z","article-title":"Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture.","volume":"44","author":"Santner","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R163","first-page":"3073","article-title":"Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.","volume":"55","author":"Yue","year":"1995","journal-title":"Cancer Res"},{"key":"2019041122241475200_R164","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1006004930930","article-title":"The effects of aromatase inhibitors and antiestrogens in the nude mouse model.","volume":"50","author":"Lu","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1006225601046","article-title":"The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer.","volume":"57","author":"Lu","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R166","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-04-2782","article-title":"Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model.","volume":"65","author":"Jelovac","year":"2005","journal-title":"Cancer Res"},{"key":"2019041122241475200_R167","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/jnci\/djh076","article-title":"Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.","volume":"96","author":"Long","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"2019041122241475200_R168","first-page":"2658","article-title":"Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole.","volume":"80","author":"Klein","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R169","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0960-0760(93)90283-3","article-title":"The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer.","volume":"44","author":"Demers","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s002800000113","article-title":"Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women.","volume":"46","author":"Dowsett","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"2019041122241475200_R171","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.critrevonc.2005.05.005","article-title":"Aromatase inhibitors as adjuvant treatment of breast cancer.","volume":"57","author":"Geisler","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"2019041122241475200_R172","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/bjc.1996.531","article-title":"Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.","volume":"74","author":"Geisler","year":"1996","journal-title":"Br J Cancer"},{"key":"2019041122241475200_R173","first-page":"2089","article-title":"In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.","volume":"4","author":"Geisler","year":"1998","journal-title":"Clin Cancer Res"},{"key":"2019041122241475200_R174","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000227752","article-title":"A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancer.","volume":"54(Suppl 2)","author":"Kleeberg","year":"1997","journal-title":"Oncology"},{"key":"2019041122241475200_R175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0039-128X(93)90029-M","article-title":"Synthesis and aromatase inhibition by potential metabolites of exemestane (6-methylenandrosta-1,4-diene-3,17-dione).","volume":"58","author":"Buzzetti","year":"1993","journal-title":"Steroids"},{"key":"2019041122241475200_R176","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/02841869609083962","article-title":"Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients.","volume":"35(Suppl 5)","author":"Trunet","year":"1996","journal-title":"Acta Oncol"},{"key":"2019041122241475200_R177","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/(SICI)1097-0142(19970715)80:2<218::AID-CNCR8>3.0.CO;2-P","article-title":"A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.","volume":"80","author":"Ingle","year":"1997","journal-title":"Cancer"},{"key":"2019041122241475200_R178","first-page":"741","article-title":"[CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study in postmenopausal women with advanced or recurrent breast cancer (no. 2)\u2014evaluation of efficacy and safety at the recommended clinical dose CGS20267 Study Group]. [Japanese].","volume":"29","author":"Kimijima","year":"2002","journal-title":"Gan to Kagaku Ryoho"},{"key":"2019041122241475200_R179","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/1097-0142(19950415)75:8<2132::AID-CNCR2820750816>3.0.CO;2-U","article-title":"Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer.","volume":"75","author":"Lipton","year":"1995","journal-title":"Cancer"},{"key":"2019041122241475200_R180","first-page":"5933","article-title":"Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.","volume":"52","author":"Evans","year":"1992","journal-title":"Cancer Res"},{"key":"2019041122241475200_R181","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1200\/JCO.1999.17.11.3418","article-title":"Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group.","volume":"17","author":"Jones","year":"1999","journal-title":"J Clin Oncol"},{"key":"2019041122241475200_R182","first-page":"1101","article-title":"Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.","volume":"3","author":"Johannessen","year":"1997","journal-title":"Clin Cancer Res"},{"key":"2019041122241475200_R183","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0959-8049(00)00041-1","article-title":"High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment.","volume":"36","author":"Kvinnsland","year":"2000","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"2019041122241475200_R184","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3816\/CBC.2000.s.004","article-title":"Promising results with exemestane in the first-line treatment of metastatic breast cancer: a randomized phase II EORTC trial with a tamoxifen control","volume":"1","author":"Paridaens","year":"2000","journal-title":"Clin Breast Cancer"},{"key":"2019041122241475200_R185","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/bjc.1995.451","article-title":"Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.","volume":"72","author":"Zilembo","year":"1995","journal-title":"Br J Cancer"},{"key":"2019041122241475200_R186","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO;2-0","article-title":"A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.","volume":"79","author":"Buzdar","year":"1997","journal-title":"Cancer"},{"key":"2019041122241475200_R187","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/cncr.10908","article-title":"An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.","volume":"95","author":"Buzdar","year":"2002","journal-title":"Cancer"},{"key":"2019041122241475200_R188","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1023\/A:1008226721932","article-title":"Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR\/BC3).","volume":"9","author":"Gershanovich","year":"1998","journal-title":"Ann Oncol"},{"key":"2019041122241475200_R189","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0959-8049(03)00602-6","article-title":"Efficacy of tamoxifen following anastrozole (\u2018Arimidex\u2019) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women.","volume":"39","author":"Thu\u0308rlimann","year":"2003","journal-title":"Eur J Cancer"},{"key":"2019041122241475200_R190","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y","article-title":"Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.","volume":"92","author":"Bonneterre","year":"2001","journal-title":"Cancer"},{"key":"2019041122241475200_R191","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0959-8049(03)00326-5","article-title":"Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results.","volume":"39","author":"Nabholtz","year":"2003","journal-title":"Eur J Cancer"},{"key":"2019041122241475200_R192","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041122241475200_R193","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer.","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"2019041122241475200_R194","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1\u201398.","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"2019041122241475200_R195","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdi326","article-title":"Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.","volume":"16","author":"Goldhirsch","year":"2005","journal-title":"Ann Oncol"},{"key":"2019041122241475200_R196","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.09.121","article-title":"American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.","volume":"23","author":"Winer","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019041122241475200_R197","first-page":"1081","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med [Errata (2004) 351:2461 and (2006) 355:1746]"},{"key":"2019041122241475200_R198","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","article-title":"Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years\u2019 adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.","volume":"366","author":"Jakesz","year":"2005","journal-title":"Lancet"},{"key":"2019041122241475200_R199","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2\u20133 years\u2019 tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet [Erratum (2007) 369:906]"},{"key":"2019041122241475200_R200","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1470-2045(06)70948-2","article-title":"Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis.","volume":"7","author":"Jonat","year":"2006","journal-title":"Lancet Oncol [Erratum (2007) 8:6]"},{"key":"2019041122241475200_R201","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/cncr.22513","article-title":"Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials.","volume":"109","author":"Boccardo","year":"2007","journal-title":"Cancer"},{"key":"2019041122241475200_R202","author":"Mouridsen"},{"key":"2019041122241475200_R203","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/annonc\/mdf083","article-title":"Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism.","volume":"13","author":"Bajetta","year":"2002","journal-title":"Ann Oncol"},{"key":"2019041122241475200_R204","first-page":"201","article-title":"Cardiovascular safety profiles of aromatase inhibitors: a comparative review.","volume":"30","author":"Nabholtz","year":"2006","journal-title":"Drug Saf [Erratum (2007)"},{"key":"2019041122241475200_R205","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1200\/JCO.2005.92.003","article-title":"Neoadjuvant endocrine therapy for breast cancer: more questions than answers.","volume":"23","author":"Ellis","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019041122241475200_R206","first-page":"2229","article-title":"The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.","volume":"6","author":"Dixon","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2019041122241475200_R207","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1023\/A:1013128213451","article-title":"Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study.","volume":"12","author":"Eiermann","year":"2001","journal-title":"Ann Oncol"},{"key":"2019041122241475200_R208","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1200\/JCO.2001.19.18.3808","article-title":"Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and\/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.","volume":"19","author":"Ellis","year":"2001","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"2019041122241475200_R209","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1677\/erc.1.01023","article-title":"Elevated ERK1\/ERK2\/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation","volume":"12","author":"Martin","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"Suppl 1","key":"2019041122241475200_R210","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1677\/erc.1.01018","article-title":"Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity","volume":"2","author":"Santen","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"2019041122241475200_R211","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1158\/0008-5472.CAN-04-4502","article-title":"Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole.","volume":"65","author":"Jelovac","year":"2005","journal-title":"Cancer Res"},{"key":"2019041122241475200_R212","first-page":"2918","article-title":"Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.","volume":"80","author":"Masamura","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R213","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1210\/endo.139.10.6229","article-title":"Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.","volume":"139","author":"Jeng","year":"1998","journal-title":"Endocrinology"},{"key":"2019041122241475200_R214","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-0760(01)00189-3","article-title":"The role of mitogen-activated protein (MAP) kinase in breast cancer.","volume":"80","author":"Santen","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R215","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tem.2005.06.010","article-title":"Estrogen rapid action via protein complex formation involving ER\u03b1 and Src.","volume":"16","author":"Song","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"2019041122241475200_R216","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/jnci\/93.22.1714","article-title":"Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17\u03b2-estradiol.","volume":"93","author":"Song","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2019041122241475200_R217","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1021649019025","article-title":"Apoptotic action of estrogen.","volume":"8","author":"Song","year":"2003","journal-title":"Apoptosis"},{"key":"2019041122241475200_R218","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.0308334100","article-title":"The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor \u03b1 to the plasma membrane.","volume":"101","author":"Song","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122241475200_R219","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1158\/0008-5472.CAN-07-2707","article-title":"Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.","volume":"68","author":"Massarweh","year":"2008","journal-title":"Cancer Res"},{"key":"2019041122241475200_R220","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1158\/1078-0432.CCR-06-2540","article-title":"Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities.","volume":"13","author":"Massarweh","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2019041122241475200_R221","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/endo.141.1.7270","article-title":"Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo.","volume":"141","author":"Shim","year":"2000","journal-title":"Endocrinology"},{"key":"2019041122241475200_R222","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jsbmb.2006.12.104","article-title":"Demethylation of promoter C region of estrogen receptor \u03b1 gene is correlated with its enhanced expression in estrogen-ablation resistant MCF-7 cells.","volume":"105","author":"Sogon","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R223","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10495-005-1903-2","article-title":"Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells.","volume":"10","author":"Song","year":"2005","journal-title":"Apoptosis"},{"key":"2019041122241475200_R224","author":"Sabnis"},{"key":"2019041122241475200_R225","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/ijc.21222","article-title":"Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.","volume":"117","author":"Yue","year":"2005","journal-title":"Int J Cancer"},{"key":"2019041122241475200_R226","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1158\/0008-5472.CAN-07-5999","article-title":"Stopping treatment can reverse acquired resistance to letrozole.","volume":"68","author":"Sabnis","year":"2008","journal-title":"Cancer Res"},{"key":"2019041122241475200_R227","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/0008-5472.CAN-08-0857","article-title":"Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogen.","volume":"69","author":"Sabnis","year":"2009","journal-title":"Cancer Res"},{"issue":"Suppl 4","key":"2019041122241475200_R228","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1186\/bcr2180","article-title":"Integration of endocrine therapy with targeted agents","volume":"10","author":"Johnston","year":"2008","journal-title":"Breast Cancer Res"},{"key":"2019041122241475200_R229","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.breast.2006.01.007","article-title":"Postmenopausal advanced breast cancer: options for therapy after tamoxifen and aromatase inhibitors.","volume":"15","author":"Dodwell","year":"2006","journal-title":"Breast"},{"key":"2019041122241475200_R230","author":"Mackey","year":"2006"},{"key":"2019041122241475200_R231","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10549-006-9307-8","article-title":"The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers.","volume":"102","author":"Marcom","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122241475200_R232","author":"Kaufman","year":"2006"},{"key":"2019041122241475200_R233","author":"Cristofanilli"},{"key":"2019041122241475200_R234","author":"Baselga","year":"2005"},{"key":"2019041122241475200_R235","author":"Chow","year":"2006"},{"key":"2019041122241475200_R236","author":"Baselga","year":"2007"},{"key":"2019041122241475200_R237","doi-asserted-by":"crossref","first-page":"11762","DOI":"10.1158\/0008-5472.CAN-05-2792","article-title":"Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1\u03b1 on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy.","volume":"65","author":"Safi","year":"2005","journal-title":"Cancer Res"},{"key":"2019041122241475200_R238","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1210\/en.2006-0355","article-title":"Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1.","volume":"147","author":"Urs","year":"2006","journal-title":"Endocrinology"},{"key":"2019041122241475200_R239","first-page":"1763","author":"Santen","year":"2007"},{"key":"2019041122241475200_R240","first-page":"3180","article-title":"Overexpression of int-5\/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.","volume":"56","author":"Tekmal","year":"1996","journal-title":"Cancer Res"},{"key":"2019041122241475200_R241","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3835(01)00478-5","article-title":"Acceleration of mammary neoplasia in aromatase transgenic mice by 7,12-dimethylbenz[a]anthracene.","volume":"167","author":"Keshava","year":"2001","journal-title":"Cancer Lett"},{"key":"2019041122241475200_R242","first-page":"63","article-title":"Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.","volume":"1766","author":"Cavalieri","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"2019041122241475200_R243","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-1110(90)90018-7","article-title":"Genotoxic effects of estrogens.","volume":"238","author":"Liehr","year":"1990","journal-title":"Mutat Res"},{"key":"2019041122241475200_R244","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMra050776","article-title":"Estrogen carcinogenesis in breast cancer.","volume":"354","author":"Yager","year":"2006","journal-title":"N Engl J Med"},{"key":"2019041122241475200_R245","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/0006-291X(81)90265-5","article-title":"Solubilization and partial purification of human placental cytochromes P-450.","volume":"103","author":"Pasanen","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122241475200_R246","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0003-9861(85)90525-9","article-title":"Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 (P-450AROM), and their use in its purification.","volume":"243","author":"Mendelson","year":"1985","journal-title":"Arch Biochem Biophys"},{"key":"2019041122241475200_R247","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1016\/S0021-9258(18)61364-X","article-title":"Purification and characterization of human placental aromatase cytochrome P-450.","volume":"262","author":"Kellis Jr","year":"1987","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R248","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0039-128X(83)90058-2","article-title":"Immunoaffinity purification of aromatase cytochrome P-450 from human placental microsomes, metabolic switching from aromatization to 1\u03b2 and 2\u03b2-monohydroxylation, and recognition of aromatase isozymes.","volume":"50","author":"Osawa","year":"1987","journal-title":"Steroids"},{"key":"2019041122241475200_R249","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0039-128X(83)90060-0","article-title":"Purification and characterization of aromatase from human placenta.","volume":"50","author":"Hall","year":"1987","journal-title":"Steroids"},{"key":"2019041122241475200_R250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0021-9673(01)87439-2","article-title":"Purification of oestrogen synthetase by high-performance liquid chromatography. Two membrane-bound enzymes from the human placenta.","volume":"326","author":"Muto","year":"1985","journal-title":"J Chromatogr"},{"key":"2019041122241475200_R251","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1073\/pnas.83.17.6387","article-title":"Isolation and characterization of a complementary DNA specific for human aromatase-system cytochrome P-450 mRNA.","volume":"83","author":"Evans","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122241475200_R252","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1677\/jme.0.0080053","article-title":"Cloning and sequence analysis of the cDNA encoding P-450 aromatase (P450arom) from a rainbow trout (Oncorhynchus mykiss) ovary; relationship between the amount of P450arom mRNA and the production of oestradiol-17 \u03b2 in the ovary.","volume":"8","author":"Tanaka","year":"1992","journal-title":"J Mol Endocrinol"},{"key":"2019041122241475200_R253","doi-asserted-by":"crossref","first-page":"16358","DOI":"10.1016\/S0021-9258(18)37601-4","article-title":"The expression of a functional cDNA encoding the chicken cytochrome P-450arom (aromatase) that catalyzes the formation of estrogen from androgen.","volume":"263","author":"McPhaul","year":"1988","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R254","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/mend-4-1-3","article-title":"Aromatase cytochrome P450 in rat ovarian granulosa cells before and after luteinization: adenosine 3\u2032,5\u2032-monophosphate-dependent and independent regulation. Cloning and sequencing of rat aromatase cDNA and 5\u2032 genomic DNA.","volume":"4","author":"Hickey","year":"1990","journal-title":"Mol Endocrinol"},{"key":"2019041122241475200_R255","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0003-9861(91)90354-L","article-title":"Isolation of a full-length cDNA encoding mouse aromatase P450.","volume":"285","author":"Terashima","year":"1991","journal-title":"Arch Biochem Biophys"},{"key":"2019041122241475200_R256","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1073\/pnas.85.23.8948","article-title":"Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells.","volume":"85","author":"Corbin","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122241475200_R257","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0006-291X(88)80903-3","article-title":"Cloning of a complete cDNA encoding human aromatase: immunochemical identification and sequence analysis.","volume":"156","author":"Harada","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122241475200_R258","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0014-5793(89)81373-0","article-title":"Alternative usage of different poly(A) addition signals for two major species of mRNA encoding human aromatase P-450.","volume":"247","author":"Toda","year":"1989","journal-title":"FEBS Lett"},{"key":"2019041122241475200_R259","doi-asserted-by":"crossref","first-page":"19385","DOI":"10.1016\/S0021-9258(19)47313-4","article-title":"Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis.","volume":"264","author":"Means","year":"1989","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R260","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-291X(90)91954-Q","article-title":"Structural characterization of the human estrogen synthetase (aromatase) gene.","volume":"166","author":"Harada","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122241475200_R261","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1432-1033.1990.tb19372.x","article-title":"Structural and functional characterization of human aromatase P-450 gene.","volume":"193","author":"Toda","year":"1990","journal-title":"Eur J Biochem"},{"key":"2019041122241475200_R262","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1210\/mend-5-12-2005","article-title":"Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues.","volume":"5","author":"Means","year":"1991","journal-title":"Mol Endocrinol"},{"key":"2019041122241475200_R263","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1432-1033.1993.tb17772.x","article-title":"Molecular cloning of a cDNA showing alternative splicing of the 5\u2032-untranslated sequence of mRNA for human aromatase P-450.","volume":"213","author":"Toda","year":"1993","journal-title":"Eur J Biochem"},{"key":"2019041122241475200_R264","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1016\/S0021-9258(18)99159-3","article-title":"Tissue-specific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta.","volume":"266","author":"Mahendroo","year":"1991","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2004-823022","article-title":"Organization of the human aromatase p450 (CYP19) gene.","volume":"22","author":"Bulun","year":"2004","journal-title":"Semin Reprod Med"},{"key":"2019041122241475200_R266","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1095\/biolreprod53.5.1151","article-title":"Demonstration of tissue-specific promoters in nonprimate species that express aromatase P450 in placentae.","volume":"53","author":"Hinshelwood","year":"1995","journal-title":"Biol Reprod"},{"key":"2019041122241475200_R267","doi-asserted-by":"crossref","first-page":"13561","DOI":"10.1074\/jbc.270.22.13561","article-title":"Ad4BP\/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary.","volume":"270","author":"Michael","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R268","doi-asserted-by":"crossref","first-page":"16449","DOI":"10.1074\/jbc.270.27.16449","article-title":"Aromatase P450 gene expression in human adipose tissue. Role of a Jak\/STAT pathway in regulation of the adipose-specific promoter.","volume":"270","author":"Zhao","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R269","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1158\/0008-5472.657.65.2","article-title":"Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer.","volume":"65","author":"Zhou","year":"2005","journal-title":"Cancer Res"},{"key":"2019041122241475200_R270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0960-0760(01)00129-7","article-title":"Regulation of aromatase activity in bone-derived cells: possible role of mitogen-activated protein kinase.","volume":"79","author":"Shozu","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R271","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbspin.2005.02.005","article-title":"Aromatase and regulation of bone remodeling.","volume":"73","author":"Ribot","year":"2006","journal-title":"Joint Bone Spine"},{"key":"2019041122241475200_R272","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0960-0760(03)00346-7","article-title":"Multiple mechanisms control brain aromatase activity at the genomic and non-genomic level.","volume":"86","author":"Balthazart","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R273","doi-asserted-by":"crossref","first-page":"20591","DOI":"10.1074\/jbc.M201117200","article-title":"Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes.","volume":"277","author":"Clyne","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041122241475200_R274","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mce.2003.11.001","article-title":"Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue.","volume":"215","author":"Clyne","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122241475200_R275","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0960-0760(03)00343-1","article-title":"Regulation of aromatase gene expression in Leydig cells and germ cells.","volume":"86","author":"Bourguiba","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R276","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.steroids.2008.01.017","article-title":"Aromatase expression in the ovary: hormonal and molecular regulation.","volume":"73","author":"Stocco","year":"2008","journal-title":"Steroids"},{"key":"2019041122241475200_R277","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsbmb.2005.04.016","article-title":"Transcriptional regulation of aromatase in placenta and ovary.","volume":"95","author":"Mendelson","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R278","first-page":"1309","article-title":"Identification of a cyclic adenosine 3\u2032,5\u2032-monophosphate-response element in the rat aromatase promoter that is required for transcriptional activation in rat granulosa cells and R2C Leydig cells.","volume":"8","author":"Fitzpatrick","year":"1994","journal-title":"Mol Endocrinol"},{"key":"2019041122241475200_R279","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/rp.57.1.195","article-title":"Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization.","volume":"57","author":"Richards","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"2019041122241475200_R280","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00535-008-2185-6","article-title":"Molecular insights into Peutz-Jeghers syndrome: two probands with a germline mutation of LKB1.","volume":"43","author":"Hosogi","year":"2008","journal-title":"J Gastroenterol"},{"key":"2019041122241475200_R281","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJM199101313240507","article-title":"An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia.","volume":"324","author":"Coen","year":"1991","journal-title":"N Engl J Med"},{"key":"2019041122241475200_R282","first-page":"1616","article-title":"Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads.","volume":"78","author":"Bulun","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R283","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.1038\/sj.onc.1208985","article-title":"Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression.","volume":"24","author":"Hu","year":"2005","journal-title":"Oncogene"},{"key":"2019041122241475200_R284","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1152\/ajpendo.00242.2006","article-title":"Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells","volume":"292","author":"Ghosh","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041122241475200_R285","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1210\/jc.2006-1364","article-title":"BRCA1 negatively regulates the cancer-associated aromatase promoters I, 3 and II in breast adipose fibroblasts and malignant epithelial cells.","volume":"91","author":"Lu","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R286","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1073\/pnas.90.23.11312","article-title":"Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis.","volume":"90","author":"Harada","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122241475200_R287","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsbmb.2005.04.002","article-title":"Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.","volume":"95","author":"Chen","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R288","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.embor.7400963","article-title":"Structural plasticity in the oestrogen receptor ligand-binding domain.","volume":"8","author":"Nettles","year":"2007","journal-title":"EMBO Rep [Erratum (2007) 8:610]"},{"key":"2019041122241475200_R289","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0960-0760(93)90243-P","article-title":"A detailed molecular model for human aromatase.","volume":"44","author":"Laughton","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R290","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0960-0760(95)00033-V","article-title":"A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 aromatase).","volume":"53","author":"Koymans","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R291","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1097-2765(00)80408-6","article-title":"Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity.","volume":"5","author":"Williams","year":"2000","journal-title":"Mol Cell"},{"key":"2019041122241475200_R292","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0006-2952(02)01361-8","article-title":"Expression and purification of a recombinant form of human aromatase from Escherichia coli.","volume":"64","author":"Zhang","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"2019041122241475200_R293","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.steroids.2004.01.002","article-title":"Characterization of stable human aromatase expressed in E. coli.","volume":"69","author":"Kagawa","year":"2004","journal-title":"Steroids"},{"key":"2019041122241475200_R294","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(95)03524-B","article-title":"Expression of a recombinant derivative of human aromatase P450 in insect cells utilizing the baculovirus vector system","volume":"109","author":"Amarneh","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122241475200_R295","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2265.2007.02864.x","article-title":"A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestragen deficiency, adiposity and the metabolic syndrome.","volume":"67","author":"Maffei","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122241475200_R296","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tem.2006.01.004","article-title":"Of mice and men: the evolving phenotype of aromatase deficiency.","volume":"17","author":"Jones","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"2019041122241475200_R297","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1210\/jc.2005-0852","article-title":"The continuing saga of dehydroepiandrosterone (DHEA).","volume":"90","author":"Siiteri","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R298","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0022-4731(84)90002-5","article-title":"The early history of estriol.","volume":"20","author":"Diczfalusy","year":"1984","journal-title":"J Steroid Biochem"},{"key":"2019041122241475200_R299","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1210\/endo-94-4-1192","article-title":"The stimulation of uterine blood flow by various estrogens.","volume":"94","author":"Resnik","year":"1974","journal-title":"Endocrinology"},{"key":"2019041122241475200_R300","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/endo-103-1-240","article-title":"Evidence for a discontinuous requirement for estrogen in stimulation of deoxyribonucleic acid synthesis in the immature rat uterus.","volume":"103","author":"Harris","year":"1978","journal-title":"Endocrinology"},{"key":"2019041122241475200_R301","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1210\/endo-117-5-1839","article-title":"Interaction of estradiol and estriol with uterine estrogen receptor in vivo and in excised uteri or cell suspensions at 37 C: noncooperative estradiol binding and absence of estriol inhibition of estradiol-induced receptor activation and transformation.","volume":"117","author":"Mu\u0308ller","year":"1985","journal-title":"Endocrinology"},{"key":"2019041122241475200_R302","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1210\/jcem-33-2-368","article-title":"Aromatization of androstenedione by the diencephalon.","volume":"33","author":"Naftolin","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R303","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0016-6480(80)90181-1","article-title":"Aromatization and 5 \u03b1-reduction in brain and nonneural tissues of a cyclostome, Petromyzon marinus.","volume":"42","author":"Callard","year":"1980","journal-title":"Gen Comp Endocrinol"},{"key":"2019041122241475200_R304","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1095\/biolreprod21.1.33","article-title":"In vitro aromatization and other androgen transformations in the brain of the hamster (Mesocricetus auratus).","volume":"21","author":"Callard","year":"1979","journal-title":"Biol Reprod"},{"key":"2019041122241475200_R305","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/endo-103-6-2283","article-title":"Phylogenetic distribution of aromatase and other androgen-converting enzymes in the central nervous system.","volume":"103","author":"Callard","year":"1978","journal-title":"Endocrinology"},{"key":"2019041122241475200_R306","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1095\/biolreprod57.4.772","article-title":"Distribution of aromatase cytochrome P450 messenger ribonucleic acid in adult rhesus monkey brains.","volume":"57","author":"Abdelgadir","year":"1997","journal-title":"Biol Reprod"},{"key":"2019041122241475200_R307","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molbrainres.2005.07.004","article-title":"Hippocampal NMDA receptor subunit expression and watermaze learning in estrogen deficient female mice.","volume":"140","author":"Boon","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"2019041122241475200_R308","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.physbeh.2004.08.017","article-title":"Sexual partner preference, hypothalamic morphology and aromatase in rams.","volume":"83","author":"Roselli","year":"2004","journal-title":"Physiol Behav"},{"key":"2019041122241475200_R309","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jsbmb.2007.05.014","article-title":"Brain aromatase: roles in reproduction and neuroprotection.","volume":"106","author":"Roselli","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R310","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jez.a.303","article-title":"Neurosteroids and the songbird model system.","volume":"305","author":"Schlinger","year":"2006","journal-title":"J Exp Zoolog A Comp Exp Biol"},{"key":"2019041122241475200_R311","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1210\/en.2003-1098","article-title":"The volume of a sexually dimorphic nucleus in the ovine medial preoptic area\/anterior hypothalamus varies with sexual partner preference.","volume":"145","author":"Roselli","year":"2004","journal-title":"Endocrinology"},{"key":"2019041122241475200_R312","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.yhbeh.2006.07.003","article-title":"Sex steroids modulate changes in social and sexual preference during juvenile development in zebra finches.","volume":"50","author":"Adkins-Regan","year":"2006","journal-title":"Horm Behav"},{"key":"2019041122241475200_R313","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbr.2006.05.023","article-title":"Targeting steroid receptor coactivator-1 expression with locked nucleic acids antisense reveals different thresholds for the hormonal regulation of male sexual behavior in relation to aromatase activity and protein expression.","volume":"172","author":"Charlier","year":"2006","journal-title":"Behav Brain Res"},{"key":"2019041122241475200_R314","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.yfrne.2006.05.002","article-title":"Brain aromatase: new lessons from non-mammalian model systems.","volume":"27","author":"Forlano","year":"2006","journal-title":"Front Neuroendocrinol"},{"key":"2019041122241475200_R315","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000094400","article-title":"Effects of estrogen in the male rat medial amygdala: infusion of an aromatase inhibitor lowers mating and bovine serum albumin-conjugated estradiol implants do not promote mating.","volume":"83","author":"Huddleston","year":"2006","journal-title":"Neuroendocrinology"},{"key":"2019041122241475200_R316","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsbmb.2005.02.016","article-title":"Brain aromatase expression after experimental stroke: topography and time course.","volume":"96","author":"Carswell","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R317","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0306-4522(98)00340-6","article-title":"Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair.","volume":"89","author":"Garcia-Segura","year":"1999","journal-title":"Neuroscience"},{"key":"2019041122241475200_R318","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1523\/JNEUROSCI.23-25-08701.2003","article-title":"Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection.","volume":"23","author":"McCullough","year":"2003","journal-title":"J Neurosci"},{"key":"2019041122241475200_R319","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2826.2008.01713.x","article-title":"Aromatase in the brain: not just for reproduction anymore.","volume":"20","author":"Garcia-Segura","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"2019041122241475200_R320","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1210\/jc.2004-1717","article-title":"Aromatase activity and bone homeostasis in men.","volume":"89","author":"Gennari","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R321","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med [Erratum (1995) 332:131]"},{"key":"2019041122241475200_R322","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ncpendmet0477","article-title":"Recognizing rare disorders: aromatase deficiency.","volume":"3","author":"Jones","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041122241475200_R323","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0960-0760(01)00130-3","article-title":"Bone phenotype of the aromatase deficient mouse.","volume":"79","author":"Oz","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122241475200_R324","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-42-6-1081","article-title":"Intratesticular site of aromatization in the human.","volume":"42","author":"Payne","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R325","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1073\/pnas.96.14.7986","article-title":"Impairment of spermatogenesis in mice lacking a functional aromatase (Cyp 19) gene.","volume":"96","author":"Robertson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122241475200_R326","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/oxfordjournals.jncimonographs.a024244","article-title":"The role of steroid hormones in prostate carcinogenesis.","volume":"27","author":"Bosland","year":"2000","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2019041122241475200_R327","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1210\/jc.2003-030933","article-title":"Local aromatase expression in human prostate is altered in malignancy.","volume":"89","author":"Ellem","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R328","first-page":"1","article-title":"Aromatase and prostate cancer.","volume":"31","author":"Ellem","year":"2006","journal-title":"Minerva Endocrinol"},{"key":"2019041122241475200_R329","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/cncr.10844","article-title":"Selective aromatase inhibition for patients with androgen-independent prostate carcinoma.","volume":"95","author":"Smith","year":"2002","journal-title":"Cancer"},{"key":"2019041122241475200_R330","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/1097-0142(20011015)92:8<2095::AID-CNCR1550>3.0.CO;2-Y","article-title":"Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.","volume":"92","author":"Santen","year":"2001","journal-title":"Cancer"},{"key":"2019041122241475200_R331","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/jc.2005-1923","article-title":"Review: aromatase inhibitors for ovulation induction.","volume":"91","author":"Casper","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R332","first-page":"244","article-title":"Aromatase inhibition : a novel method of ovulation induction in women wtih polycystic ovarian syndrome.","volume":"10","author":"Mittwally","year":"2000","journal-title":"Reprod Technol"},{"key":"2019041122241475200_R333","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary.","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041122241475200_R334","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R335","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S0015-0282(01)02323-8","article-title":"Prospective randomized trial comparing the effects of letrozole with clomiphene citrate on follicular development, endometrial thickness, and pregnancy rates in patients undergoing superovulation prior to intrauterine insemination","volume":"76","author":"Sammour","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041122241475200_R336","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.fertnstert.2004.05.099","article-title":"Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients.","volume":"83","author":"Corti\u0301nez","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041122241475200_R337","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.fertnstert.2004.04.070","article-title":"A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation.","volume":"82","author":"Al-Fozan","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041122241475200_R338","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1472-6483(10)61140-6","article-title":"Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor.","volume":"11","author":"Fatemi","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"2019041122241475200_R339","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijgo.2003.11.010","article-title":"Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome.","volume":"85","author":"Al-Omari","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"2019041122241475200_R340","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate.","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041122241475200_R341","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.fertnstert.2005.07.230","article-title":"The outcome of 150 babies following the treatment with letrozole or letrozole plus gonadotropins","volume":"84","author":"Biljan","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041122241475200_R342","first-page":"600","article-title":"Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.","volume":"82","author":"Noble","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R343","first-page":"174","article-title":"Aromatase expression in endometriosis.","volume":"81","author":"Noble","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R344","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.fertnstert.2005.09.064","article-title":"Aromatase inhibitors: the next generation of therapeutics for endometriosis?","volume":"85","author":"Attar","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041122241475200_R345","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/deh035","article-title":"The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial.","volume":"19","author":"Soysal","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122241475200_R346","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1677\/erc.0.0060315","article-title":"Aromatase and gynecomastia.","volume":"6","author":"Braunstein","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"2019041122241475200_R347","first-page":"643","article-title":"Treatment of gynecomastia.","volume":"2","author":"Gruntmanis","year":"2001","journal-title":"Curr Opin Invest Drugs"},{"key":"2019041122241475200_R348","first-page":"113","article-title":"Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole.","volume":"62","author":"Riepe","year":"2004","journal-title":"Horm Res"},{"key":"2019041122241475200_R349","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.","volume":"80","author":"Morishima","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R350","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/jc.2007-1559","article-title":"Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.","volume":"93","author":"Mauras","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R351","author":"Dunkel","year":"2006"},{"key":"2019041122241475200_R352","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/hmg\/ddm145","article-title":"Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.","volume":"16","author":"Demura","year":"2007","journal-title":"Hum Mol Genet"},{"key":"2019041122241475200_R353","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1210\/jc.2002-021780","article-title":"Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings.","volume":"88","author":"Martin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R354","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI111888","article-title":"Familial gynecomastia with increased extraglandular aromatization of plasma carbon 19-steroids.","volume":"75","author":"Berkovitz","year":"1985","journal-title":"J Clin Invest"},{"key":"2019041122241475200_R355","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.1980.03310020036024","article-title":"Tutankhamun and his brothers. Familial gynecomastia in the eighteenth dynasty.","volume":"244","author":"Paulshock","year":"1980","journal-title":"JAMA"},{"key":"2019041122241475200_R356","first-page":"2474","author":"Santen","year":"2001"},{"key":"2019041122241475200_R357","first-page":"1348","article-title":"The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription.","volume":"83","author":"Stratakis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122241475200_R358","first-page":"834","author":"Achermann","year":"2008"},{"key":"2019041122241475200_R359","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/edrv.20.3.0370","article-title":"Estrogen receptor null mice: what have we learned and where will they lead us?","volume":"20","author":"Couse","year":"1999","journal-title":"Endocr Rev [Erratum (1999) 20:459]"},{"key":"2019041122241475200_R360","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199707103370204","article-title":"Effect of testosterone and estradiol in a man with aromatase deficiency.","volume":"337","author":"Carani","year":"1997","journal-title":"N Engl J Med"},{"key":"2019041122241475200_R361","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1006\/bbrc.1994.1163","article-title":"Novel exon 1 of the aromatase gene specific for aromatase transcripts in human brain.","volume":"198","author":"Honda","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122241475200_R362","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2003-030313","article-title":"Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.","volume":"89","author":"Maffei","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/30\/4\/343\/10334655\/edrv0343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T10:46:53Z","timestamp":1685011613000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/30\/4\/343\/2355213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,1]]},"references-count":362,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2008-0016","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,1]]}}}